Cytori Therapeutics, Inc., a company focused on developing autologous cell therapies from adipose tissue for the treatment of several conditions,…
Articles by Patrícia Silva, PhD
Throughout 2015, Scleroderma News reported on studies characterizing scleroderma disease subsets, unique features, case reports, potential therapies and strategies for…
Boehringer Ingelheim recently announced the enrollment of the first patient in the Phase 3 clinical trial SENSCIS (Safety and Efficacy of…
Protagen AG, a leader in the development of novel molecular diagnostics for autoimmune diseases, recently launched the Multilisa BICD2,…
Researchers in Switzerland recently presented data revealing that patients with systemic sclerosis are likely to be deficient in certain micronutrients, and…
A new and promising way of classifying the debilitating autoimmune disease scleroderma has been developed by researchers in Australia. Their study, published…
A new case study revealed that long-term treatment with therapeutic plasma exchange (TPE) led to successful symptom management and disease remission in…
iBio, Inc., a biotechnology company focused on developing plant-based therapies for diseases that include scleroderma, recently presented new data…
Genkyotex, a company focused on developing therapies for hard-to-treat chronic diseases, recently announced that the company’s lead product candidate…
The nonprofit association phaware is dedicated to raising global awareness of a common complication in patients with scleroderma, the chronic lung disease known as pulmonary…